Literature DB >> 19487286

Multipotent CD15+ cancer stem cells in patched-1-deficient mouse medulloblastoma.

Ryan J Ward1, Lilian Lee, Kevin Graham, Thevagi Satkunendran, Koichi Yoshikawa, Erick Ling, Lauren Harper, Ryan Austin, Erica Nieuwenhuis, Ian D Clarke, Chi-Chung Hui, Peter B Dirks.   

Abstract

Subpopulations of tumorigenic cells have been identified in many human tumors, although these cells may not be very rare in some types of cancer. Here, we report that medulloblastomas arising from Patched-1-deficient mice contain a subpopulation of cells that show a neural precursor phenotype, clonogenic and multilineage differentiation capacity, activated Hedgehog signaling, wild-type Patched-1 expression, and the ability to initiate tumors following allogeneic orthotopic transplantation. The normal neural stem cell surface antigen CD15 enriches for the in vitro proliferative and in vivo tumorigenic potential from uncultured medulloblastomas, supporting the existence of a cancer stem cell hierarchy in this clinically relevant mouse model of cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19487286     DOI: 10.1158/0008-5472.CAN-09-0342

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  85 in total

Review 1.  Potential therapeutic implications of cancer stem cells in glioblastoma.

Authors:  Lin Cheng; Shideng Bao; Jeremy N Rich
Journal:  Biochem Pharmacol       Date:  2010-05-10       Impact factor: 5.858

2.  Itraconazole side chain analogues: structure-activity relationship studies for inhibition of endothelial cell proliferation, vascular endothelial growth factor receptor 2 (VEGFR2) glycosylation, and hedgehog signaling.

Authors:  Wei Shi; Benjamin A Nacev; Blake T Aftab; Sarah Head; Charles M Rudin; Jun O Liu
Journal:  J Med Chem       Date:  2011-10-05       Impact factor: 7.446

Review 3.  The cancer stem cell paradigm: a new understanding of tumor development and treatment.

Authors:  Johnathan D Ebben; Daniel M Treisman; Michael Zorniak; Raman G Kutty; Paul A Clark; John S Kuo
Journal:  Expert Opin Ther Targets       Date:  2010-06       Impact factor: 6.902

Review 4.  Molecular signaling of the epithelial to mesenchymal transition in generating and maintaining cancer stem cells.

Authors:  Gaoliang Ouyang; Zhe Wang; Xiaoguang Fang; Jia Liu; Chaoyong James Yang
Journal:  Cell Mol Life Sci       Date:  2010-03-18       Impact factor: 9.261

Review 5.  Stem cell glycolipids.

Authors:  Makoto Yanagisawa
Journal:  Neurochem Res       Date:  2010-12-16       Impact factor: 3.996

6.  Inhibition of WNT signaling attenuates self-renewal of SHH-subgroup medulloblastoma.

Authors:  J Rodriguez-Blanco; L Pednekar; C Penas; B Li; V Martin; J Long; E Lee; W A Weiss; C Rodriguez; N Mehrdad; D M Nguyen; N G Ayad; P Rai; A J Capobianco; D J Robbins
Journal:  Oncogene       Date:  2017-07-17       Impact factor: 9.867

7.  Dose-dependent proteomic analysis of glioblastoma cancer stem cells upon treatment with γ-secretase inhibitor.

Authors:  Lan Dai; Jintang He; Yashu Liu; Jaeman Byun; Anuradha Vivekanandan; Subramaniam Pennathur; Xing Fan; David M Lubman
Journal:  Proteomics       Date:  2011-10-24       Impact factor: 3.984

8.  Effects of inhibition of hedgehog signaling on cell growth and migration of uveal melanoma cells.

Authors:  Fei Duan; Ming Lin; Chuanyin Li; Xia Ding; Guanxiang Qian; He Zhang; Shengfang Ge; Xianqun Fan; Jin Li
Journal:  Cancer Biol Ther       Date:  2014-03-11       Impact factor: 4.742

9.  A CK1α Activator Penetrates the Brain and Shows Efficacy Against Drug-resistant Metastatic Medulloblastoma.

Authors:  Jezabel Rodriguez-Blanco; Bin Li; Jun Long; Chen Shen; Fan Yang; Darren Orton; Sara Collins; Noriyuki Kasahara; Nagi G Ayad; Heather J McCrea; Martine F Roussel; William A Weiss; Anthony J Capobianco; David J Robbins
Journal:  Clin Cancer Res       Date:  2018-11-28       Impact factor: 12.531

10.  Decreasing glioma recurrence through adjuvant cancer stem cell inhibition.

Authors:  Josh Neman; Rahul Jandial
Journal:  Biologics       Date:  2010-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.